greeksoup/ stock research

Clorox (CLX) FY2024 results: revenue $7.1 billion, down 4.0% on the year

Clorox Co. (CLX) reported revenue of $7.1 billion for fiscal 2024, the year ended 30 June 2024, down 4.0% on the year before. Net income was $280 million, up 87.9%, and diluted earnings per share $2.25. The figures are the company's own, from the 10-K it filed with the SEC on 8 August 2024.

Revenue
$7.1 billion
-4.0% on the year
FY2017FY2024
Operating margin
n/a
FY2017FY2024
Net income
$280 million
+87.9% on the year
FY2017FY2024
Diluted EPS
$2.25
+87.5% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue7,0937,3897,107-4.0%
Cost of revenue4,0454,4814,562-9.7%
Gross profit3,0482,9082,545+4.8%
Gross margin43.0%39.4%35.8%
Research and development126138132-8.7%
Selling, general and administrative1,1671,183954-1.4%
Interest expense90.090.01060.0%
Pre-tax income398238607+67.2%
Income tax10677.0136+37.7%
Effective tax rate26.6%32.4%22.4%
Net income280149462+87.9%
Net margin3.9%2.0%6.5%
Diluted EPS$2.25$1.20$3.73+87.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow6951,158786-40.0%
Capital expenditure212228251-7.0%
Free cash flow483930535-48.1%
Free cash flow margin6.8%12.6%7.5%
Cash from investing-175-223-229
Cash from financing-655-753-689
Depreciation and amortisation235236224-0.4%
Share-based compensation74.073.052.0+1.4%
Buybacks0.00.025.0
Dividends paid595583571+2.1%
Dividend per share$4.80$4.72$3.48+1.7%
Diluted shares, weighted125m124m124m+0.5%
Shares outstanding at period end124m124m123m+0.3%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity328220556+49.1%
Non-controlling interest164168173-2.4%
Debt2,4812,5272,711-1.8%
Operating lease liabilities334310314+7.7%
Finance lease liabilities21.021.013.00.0%
Other liabilities2,4232,6992,391-10.2%
Total liabilities and equity5,7515,9456,158-3.3%
Fixed assets1,3151,3451,334-2.2%
Goodwill1,2281,2521,558-1.9%
Intangible assets681712884-4.4%
Cash and equivalents202367183-45.0%
Receivables695688681+1.0%
Inventory637696755-8.5%
Other assets993885763+12.2%
Total assets5,7515,9456,158-3.3%

10-K for the year ended 30 June 2024, filed 8 August 2024: the filing.